Use of anti-depressants during pregnancy not linked with increased risk of stillbirth, infant death
CHICAGO – In a study that included nearly 30,000 women from Nordic countries who had filled a selective serotonin reuptake inhibitor (SSRI) prescription during pregnancy, researchers found no significant association between use of these medications during pregnancy and risk of stillbirth, neonatal death, or postneonatal death, after accounting for factors including maternal psychiatric disease, according to a study in the January 2 issue of JAMA.
"Depression during pregnancy is common with prevalences ranging between 7 percent and 19 percent in economically developed ...


